Skip to main content
. 2016 Jun 23;11(6):e0157961. doi: 10.1371/journal.pone.0157961

Fig 1. Flow Diagram of Patient Disposition in Each Study.

Fig 1

The diagram shows the numbers of patients who were enrolled/randomized, received at least one infusion of ofatumumab, completed/discontinued, and included in analysis populations in each of the three studies. DB, double-blind treatment period; OL, open-label treatment period; FU, safety follow-up.